Policy Lead
US Food and Drug Administration
Anuradha (Anu) Ramamoorthy, Ph.D. is a Policy Lead at the Office of Clinical Pharmacology (OCP), Food and Drug Administration (FDA). Anu received her Ph.D. in Medical and Molecular Genetics from Indiana University and was a postdoctoral fellow at the National institutes of Health (NIH) and the FDA. In her current role, she contributes to regulatory policy development, stakeholder engagement, and research focused on clinical pharmacology. Prior to this role, she was a Reviewer in the Genomics and Targeted Therapy Group (GTTG), OCP contributing to the regulatory review of investigational new drug (IND), new drug application (NDA), and biologic licensing application (BLA) to effectively incorporate pharmacogenomic strategies in drug development. She is co-investigator in a number of regulatory research projects that are focused on advancing the use of genomics and biomarkers in drug development and approval. Anu has been a member of ASCPT since 2007 and has served in the scientific programming committee (SPC), education and career development committees, strategic planning task force, and community and network leadership. She is currently the Past-Chair of the Development, Regulatory, and Outcomes (DRO) Network and the Vice-Chair of the SPC.
Disclosure information not submitted.
Tuesday, January 11, 2022
10:00 AM – 11:00 AM ET
Tuesday, January 11, 2022
9:00 PM – 9:40 PM ET
Friday, January 14, 2022
9:55 AM – 10:00 AM ET
Friday, March 18, 2022
3:45 PM – 4:45 PM ET
Friday, March 18, 2022
6:00 PM – 6:15 PM ET
.png)